Prevalence of coinfection with human immunodeficiency virus and hepatitis C virus in Japan.
People with human immunodeficiency virus (HIV) infection are frequently infected with hepatitis C virus (HCV), because of the common transmission routes. Since the dissemination of hyperactive antiretrovirus therapy (HAART), the morbidity and mortality associated with HIV infection have declined. However, the reduction in mortality due to opportunistic infection has made HCV-associated liver diseases the leading cause of mortality in Western countries. A similar situation is assumed in Japan, but the status of coinfection with HIV and HCV is unclear. We conducted a nationwide survey to determine the prevalence of coinfection with HIV and HCV by distributing a questionnaire to the hospitals in the HIV/AIDS Network of Japan. Among 4877 patients reported to be HIV-positive, 935 (19.2%) were also positive for the anti-HCV antibody. Most (84.1%) of the patients coinfected with HIV and HCV were recipients of blood products. These data, for the first time, show the current status of coinfection with HIV and HCV in Japan. A detailed analysis of the progression and severity of liver diseases in the coinfected patients is expected.
Koike
Kazuhiko
K
Department of Internal Medicine, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Tsukada
Kunihisa
K
Yotsuyanagi
Hiroshi
H
Moriya
Kyoji
K
Kikuchi
Yoshimi
Y
Oka
Shinichi
S
Kimura
Satoshi
S